IDEXX Laboratories (IDXX) Announces Quarterly Earnings, Beats Estimates By $0.01 EPS

IDEXX Laboratories (IDXX) posted its quarterly earnings results on Friday. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.01. The company’s revenue for the quarter was up 10.2% on a year-over-year basis.

A number of analysts have recently weighed in on IDXX shares. Analysts at Feltl & Co. raised their price target on shares of IDEXX Laboratories from $87.50 to $90.00 in a research note to investors on Monday, April 23rd. They now have a “hold” rating on the stock. On a related note, analysts at Leerink Swann upgraded shares of IDEXX Laboratories from a “market perform” rating to an “outperform” rating in a research note to investors on Monday, April 23rd. Finally, analysts at Bank of America (NYSE: BAC) raised their price target on shares of IDEXX Laboratories from $93.00 to $94.00 in a research note to investors on Friday, April 20th. They now have a “buy” rating on the stock.

IDEXX Laboratories (IDXX) opened at 86.24 on Friday. IDEXX Laboratories (IDXX) has a 52-week low of $63.83 and a 52-week high of $89.50. The company has a market cap of $4.746 billion and a price-to-earnings ratio of 29.92.

IDEXX Laboratories, Inc. (IDEXX) develops, manufactures and distributes products, and provides services primarily for the veterinary and the production animal, water testing and dairy markets.

Stay ahead of the market with Analyst Ratings Network's daily email update that provides a summary of analysts' upgrades, downgrades and new coverage. Click here to register now.

Posted by Web Inquirer Staff on 25 May 2012. Filed under Markets. You can follow any responses to this entry through the RSS 2.0. You can skip to the end and leave a response. Pinging is currently not allowed.